STING1 and head and neck squamous cell carcinoma: The observations described above indicate differential expression of STING in HPV+ and HPV− HNSCC human patient samples (Fig. 6), with cell lines exhibiting lack of type-I IFN (IFNβ) production in response to STING pathway activation (Fig. 2C).